Based on the discriminant analysis, two biomarkers, COPZ1 and PTPN1 were capable of distinguishing PD from PSP patients while the remaining biomarkers were excluded from the model. The gene discussed is PTPN1; the disease is supranuclear palsy, progressive, 1.